An issue to watch is how “digiceuticals” (digital therapeutics) will affect the wellness industry. This new generation of digital medicines that rely on software for curing or managing a disease is booming—200 deals closed in the US in the first half of this year, representing a cumulative investment of $3.4 billion. They go beyond wellness apps, whose purpose is to maintain a healthy lifestyle and…
